Royce & Associates’s CRH Medical Corporation CRHM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-475,000
| Closed | -$1.88M | – | 1075 |
|
|
2021
Q1 | $1.88M | Hold |
475,000
| – | – | 0.01% | 761 |
|
|
2020
Q4 | $1.11M | Hold |
475,000
| – | – | 0.01% | 800 |
|
|
2020
Q3 | $1.03M | Hold |
475,000
| – | – | 0.01% | 775 |
|
|
2020
Q2 | $994K | Hold |
475,000
| – | – | 0.01% | 781 |
|
|
2020
Q1 | $635K | Hold |
475,000
| – | – | 0.01% | 801 |
|
|
2019
Q4 | $1.65M | Hold |
475,000
| – | – | 0.01% | 731 |
|
|
2019
Q3 | $1.46M | Buy |
475,000
+342,000
| +257% | +$1.01M | 0.01% | 753 |
|
|
2019
Q2 | $400K | Hold |
133,000
| – | – | ﹤0.01% | 935 |
|
|
2019
Q1 | $351K | Hold |
133,000
| – | – | ﹤0.01% | 949 |
|
|
2018
Q4 | $407K | Hold |
133,000
| – | – | ﹤0.01% | 945 |
|
|
2018
Q3 | $529K | Hold |
133,000
| – | – | ﹤0.01% | 975 |
|
|
2018
Q2 | $416K | Hold |
133,000
| – | – | ﹤0.01% | 1025 |
|
|
2018
Q1 | $337K | Hold |
133,000
| – | – | ﹤0.01% | 1070 |
|
|
2017
Q4 | $350K | Hold |
133,000
| – | – | ﹤0.01% | 1066 |
|
|
2017
Q3 | $346K | Hold |
133,000
| – | – | ﹤0.01% | 1046 |
|
|
2017
Q2 | $757K | Hold |
133,000
| – | – | 0.01% | 1009 |
|
|
2017
Q1 | $1.09M | Hold |
133,000
| – | – | 0.01% | 968 |
|
|
2016
Q4 | $710K | Hold |
133,000
| – | – | ﹤0.01% | 979 |
|
|
2016
Q3 | $516K | Buy |
+133,000
| New | +$509K | ﹤0.01% | 996 |
|
Royce & Associates's CRHM Position: Q2 2021 in Review
Royce & Associates sold out of CRH Medical Corporation (CRHM) in Q2 2021, closing a stake of 475,000 shares — an estimated $1.88M sold.
Royce & Associates first reported a position in CRHM in Q3 2016 and held it in 19 quarters. The position peaked at $1.88M in Q1 2021. 1 fund tracked by Wall St. Rank holds CRHM as of Q2 2021.
- Royce & Associates reported no remaining CRH Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Royce & Associates sold 475,000 CRH Medical Corporation shares in Q2 2021, an estimated $1.88M.
- Royce & Associates first reported a position in CRH Medical Corporation in Q3 2016 and held it in 19 quarters.
- Royce & Associates's CRH Medical Corporation position peaked at $1.88M in Q1 2021.
- 1 fund tracked by Wall St. Rank held CRH Medical Corporation as of Q2 2021.
Based on Royce & Associates's 13F filing for Q2 2021, filed 6 Aug 2021.